300683.SZ
海特生物
SZSE · Healthcare · C 制造业 · CN
CNY 25.78
−11.41%Margins
Gross margin
40.9%
EBITDA margin
-25.3%
EBIT margin
-45.1%
Net margin
-44.2%
FCF margin
-14.4%
-11.2%
Return on equity
-9.4%
Return on assets
-11.4%
Return on invested capital
0.21x
Asset turnover
-CNY 29.3M
Cash from operations
—
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Mar 1, 2026